Drug · DIN 02394871
MINT-ALENDRONATE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since September 12, 2025; first marketed November 21, 2012.
- Drug Identification Number (DIN)
- 02394871
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Alendronic acid M05BA04
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ALENDRONIC ACID (ALENDRONATE SODIUM) | 70.0 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 23, 2012: NOC 13747Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named MINT-ALENDRONATE
- DIN 02394855 · Approved
- DIN 02394863 · Cancelled Post Market